ATYR Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline Without Revenue Ziff Davis Inc Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Reaction REGCO Q1 2026 Earnings EPS Surpasses Estimates Amid Steady Operational Performance CXAI Q4 2025 Earnings EPS Misses Estimates Stock Declines 9 CNP Q1 2026 Earnings Slight EPS Miss Amid Modest Stock Gains CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline